Retrospective analysis of postoperative radiotherapy for node-negative cervical carcinoma with stage IB-IIB disease

Japanese Journal of Clinical Oncology

Volumn 32, Issue 7, 2002, Pages 255-261

  Kodaira, Takeshi ^a   Fuwa, Nobukazu ^a   Nakanishi, Toru ^a   Kuzuya, Kazuo ^a   Sasaoka, Masahiro ^b   Furutani, Kazuhisa ^a   Kamata, Minoru ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; node negative; Postoperative radiotherapy; Prognostic factors

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; BLADDER INJURY; BONE INJURY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INTESTINE INJURY; LEG EDEMA; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; RADIATION DOSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROMA; TUMOR VOLUME; UNIVARIATE ANALYSIS; URETER OBSTRUCTION; UTERINE CERVIX CARCINOMA; UTERUS; ADJUVANT THERAPY; EVALUATION; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ADULT; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0036653624     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyf051     Document Type: Article

References (36)

1. Aoki Y, Sasaki M, Watanabe M, Sato T, Tsuneki I, Aida H, et al. High-risk group in node-positive patients with stage IB, IIA and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 2000;77:305-9.
2. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
3. Lai CH, Hong JH, Hsueh S, Ng KK, Chang TC, Tseng CJ, et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: An analysis of 891 cases. Cancer 1999;85:1537-46.
4. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Gynecol Oncol 1990;38:352-7.
5. Bloss JD, Berman ML, Mukhererjee J, Manetta A, Emma D, Ramsanghani NS, et al. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecol Oncol 1992;47:21-7.
6. Gauthier P, Gore I, Shingleton HM, Soong SJ, Orr JW Jr, Hatch KD. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 1985;66:569-74.
7. Sevin BU, Lu Y, Bloch DA, Nadji M, Koechli OR, Averette HE. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 1996;78:1438-46.
8. Barber BR, Sommers SC, Rotterdam H, Kwon T. Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstet Gynecol 1978;52:343-8.
9. Boyce JG, Fruchter RG, Nicastri AD, DeRegt RH, Ambiavagar PC, Reinis M, et al. Vascular invasion in Stage I carcinoma of the cervix. Cancer 1984;53:1175-80.
10. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa K, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 1992;69:181-6.
11. Stock RG, Chen AS, Flickinger JC, Kalnicki S, Seski J. Node-positive cervical cancer: Impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys 1995;31:31-6.
12. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989;33:34-9.
13. Hopkins MP, Morley GW. Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. Am J Obstet Gynecol 1991;64:1520-7.
14. Yeh SA, Wan Leung S, Wang CJ, Chen HC. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors. Gynecol Oncol 1999;72:10-5.
15. Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys 1993; 27:1051-6.
16. Kinney WK, Alvarez RD, Reid GC, Schray MF, Soong SJ, Morley GW, et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol 1989;34:258-62.
17. Annual report on the results of treatment in gynecological cancer 1982-1986. Int J Gynecol Obstet 1989;28:189-90.
18. Hogan WM, Littman P, Griner L, Miller CL, Mikuta JJ. Results of radiation therapy given after radical hysterectomy. Cancer 1982;49:1278-85.
19. Kridelka FJ, Berg DO, Neuman M, Edwards LS, Robertson G, Grant PT, et al. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study. Cancer 1999;86:2059-65.
20. Fiorica JV, Roberts WS, Greenberg H, Hoffman MS, LaPolla JP, Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol Oncol 1990;36:343-7.
21. Barter JF, Soong SJ, Shingleton HM, Hatch KD, Orr JW Jr. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 1989;32:292-6.
22. Cunningham MJ, Dunton CJ, Corn B, Noumoff J, Morgan MA, King SA, et al. Extended-field radiation therapy in early-stage cervical carcinoma: survival and complications. Gynecol Oncol 1991;43:51-4.
23. Samlal RA, van der Velden JW, Ketting BW, González González D, Ten Kate FJ, Hart AA, et al. Disease-free interval and recurrence with the Okabayashi variant of Werthheim's radical hysterectomy for stage IB and IIA cervical carcinoma. Int J Gynecol Cancer 1996;6:120-6.
24. Thomas GM, Dembo AJ. Is there a role for adjuvant radiotherapy after radical hysterectomy in early stage cervical cancer? Int J Gynecol Cancer 1991;1:1-8.
25. Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer 1997;80:1234-40.
26. Morita K. Cancer of the cervix. In: Vahrson HW, Brady LW, Heilmann H-P, editors. Radiation Oncology of Gynecological Cancers. Berlin: Springer, 1997;169-73.
27. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
28. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
29. Mantle N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
30. Cox DR. Regression models and life table. J R Stat Soc 1972;34:197-220.
31. Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF Jr. Stage IB and IIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 1997;66:31-5.
32. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 1999;73:177-83.
33. Remy JC, di Maio T, Fruchter RG, Sedlis A, Boyce JG, Sohn CK, et al. Adjunctive radiation after radical hysterectomy in stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 1990;38:161-5.
34. Vavra N, Kucera H, Denison U, Salzer H, Schemper M, Sevelda P. The value of adjuvant irradiation in patients with cervical carcinoma in histopathological stage Ib and negative lymph nodes. Strahlenther Onkol 1991;167:509-13.
35. Takamura A, Mizoe J, Arimoto T, Kamada T, Shiarto H, Matsuoka Y, et al. Is postoperative radiotherapy beneficial in the management of stage I-II squamous-cell carcinoma of the uterine cervix with negative metastatic nodes and positive parametrial involvement?: A retrospective review of 70 patients. Asia Oceania J Obstet Gynaecol 1993;19:145-51.
36. Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol 1994; 54:4-9.